Histologic and histomorphometric assessment of sinus-floor augmentation with beta-tricalcium phosphate alone or in combination with pure-platelet-rich plasma or platelet-rich fibrin: A randomized clinical trial

2017 ◽  
Vol 19 (5) ◽  
pp. 959-967 ◽  
Author(s):  
Songül Cömert Kılıç ◽  
Metin Güngörmüş ◽  
Seçil Nazife Parlak
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Tricalcium Phosphate ◽  
Platelet Rich Plasma ◽  
Platelet Rich Fibrin ◽  
Beta Tricalcium Phosphate ◽  
Sinus Floor Augmentation ◽  
Sinus Floor

Histomorphometry of human sinus floor augmentation using a porous beta-tricalcium phosphate: a prospective study

2004 ◽  
Vol 15 (6) ◽  
pp. 724-732 ◽  
Author(s):  
Ilara R. Zerbo ◽  
Steven A. Zijderveld ◽  
Anje de Boer ◽  
Antonius L. J. J. Bronckers ◽  
Gert de Lange ◽  
...  
Keyword(s):  
Prospective Study ◽  
Tricalcium Phosphate ◽  
Beta Tricalcium Phosphate ◽  
Sinus Floor Augmentation ◽  
Sinus Floor ◽  
A Prospective Study

Monophasic ß-TCP vs. biphasic HA/ß-TCP in two-stage sinus floor augmentation procedures - a prospective randomized clinical trial

2016 ◽  
Vol 28 (10) ◽  
pp. e175-e183 ◽  
Author(s):  
Damir Jelusic ◽  
Matthias L. Zirk ◽  
Tim Fienitz ◽  
Darije Plancak ◽  
Ivan Puhar ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Two Stage ◽  
Prospective Randomized Clinical Trial ◽  
Sinus Floor Augmentation ◽  
Sinus Floor

scholarly journals Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate

2021 ◽  
Vol 18 (19) ◽  
pp. 9975
Author(s):  
Eugenio Velasco-Ortega ◽  
Angela Sierra-Baztan ◽  
Alvaro Jiménez-Guerra ◽  
Antonio España-López ◽  
Iván Ortiz-Garcia ◽  
...  
Keyword(s):  
Maxillary Sinus ◽  
Tricalcium Phosphate ◽  
Sinus Surgery ◽  
Lateral Sinus ◽  
Beta Tricalcium Phosphate ◽  
Sinus Floor Augmentation ◽  
Maxillary Sinus Floor ◽  
Sinus Floor ◽  
Maxillary Sinus Floor Augmentation

Introduction. The aim of this study was to show the long-term clinical outcomes of implants placed in maxillary sinus floor augmentation (MFSA) using beta-tricalcium phosphate (β-TCP). Patients and methods. Maxillary patients were diagnosed for MFSA and used beta- β-TCP. After the lateral sinus surgery, implants were loaded at 6 months with restorations. The clinical follow-up was at 10 years. Results. One hundred and one patients (58 females and 43 males) were treated with MFSA. Twenty-nine patients (28.7%) had a history of periodontitis. Thirty-three patients (32.7%) were smokers. One hundred and twenty-one MFSA, 81 unilateral and 20 bilateral sites, with 234 implants were performed. The average vertical bone height available was 4.92 ± 1.83 mm. The average vertical bone gain obtained was 6.95 ± 2.19 mm following MFSA. The implant cumulative survival rate was 97.2%. Three implants (1.3%) were lost during the healing period. Six implants (2.6%) were lost by peri-implantitis. One hundred and fifteen restorations were placed in the patients. Mean marginal bone loss was 1.93 mm ± 1.03 mm. Six patients (27.3%) showed technical complications. Thirty-six implants (15.3%) in 14 patients (13.9%) were associated with peri-implantitis. Conclusions. This study indicates that treatment with implant-supported restoration by MFSA using β-TCP constitutes a successful implant approach.

Sign in / Sign up

Export Citation Format

Share Document